BENEFIT Act of 2017
Latest action · Aug 11, 2017 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 4, 2017
- Passed SenateAug 3, 2017
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)
Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2017 or the BENEFIT Act of 2017
(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to consider patient-focused drug development data, such as patient preferences, patient-reported outcomes, and patient experiences, as part of the risk-benefit assessment of new drugs. Following approval of a drug, the FDA must include a description of how this information was considered in its statement of patient experience.Cosponsors 1
Members who signed on, in the order they did. All signed on May 4, 2017.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MN | Amy Klobuchar | Original | May 4, 2017 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred May 4, 2017Discharged Aug 3, 2017 |
| House | Energy and Commerce Committee | Referred Aug 4, 2017 |
| Health Subcommittee | Referred Aug 11, 2017 |
Actions 9
Everything that happened, newest first.
- Aug 11, 2017Referred to the Subcommittee on Health.
- Aug 4, 2017Received in the House.
- Aug 4, 2017Referred to the House Committee on Energy and Commerce.
- Aug 3, 2017Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.(consideration: CR S4787-4788)
- Aug 3, 2017Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S4787-4788)
- Aug 3, 2017Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent. (text: CR S4788)
- Aug 3, 2017Message on Senate action sent to the House.
- May 4, 2017Introduced in Senate
- May 4, 2017Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S4787, S4809Text printed S4788 | Lamar Alexander R-TN, Roger F. Wicker R-MS | Aug 3, 2017 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 3385 | BENEFIT Act of 2020 | Reintroduced Bill | Mar 4, 2020 |
Titles 5
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.
- Short Titles as Introduced
- BENEFIT Act of 2017
- Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2017
- Short Titles as Passed Senate
- BENEFIT Act of 2017
- Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2017
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 3
Each version as it was printed, newest first.
- Aug 4, 2017Referred in House
- Aug 3, 2017Engrossed in Senate
- May 4, 2017Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
